ReviewCurrent reviews in musculoskeletal medicine2026
Management of Ulnar Collateral Ligament Injuries of the Elbow.
Review in Current reviews in musculoskeletal medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purpose of reviewUlnar collateral ligament (UCL) injuries are increasingly prevalent among overhead throwing athletes, with reconstruction rates rising 193% from 2002 to 2011 and an annual 9% increase among adolescents. This review synthesizes current evidence on the anatomy, biomechanics, clinical evaluation, and management of UCL injuries, with a focus on comparative outcomes across nonsurgical and surgical treatment strategies. KEY
findingsNonsurgical management achieves return to sport in 80-100% of non-throwing athletes, while outcomes in overhead throwers are highly dependent on tear location, with proximal tears yielding superior success rates (89.7%) compared to distal tears (41.2%). Platelet-rich plasma remains controversial. UCL reconstruction achieves 80-97% return to play at 12-14 months; however, return to pre-injury performance is less consistent (67-87%). Primary repair with internal brace augmentation offers comparable return-to-play rates (98%) with a faster recovery timeline (9.2 versus 13.4 months) in appropriately selected patients with acute avulsion injuries. Treatment decisions should be individualized based on injury characteristics, tear location, tissue quality, and patient competitive goals. The proposed treatment algorithm stratifies management by tear location to facilitate evidence-based decision-making and realistic preoperative counseling.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.